American University Washington Colleague of Law October 2010 Judit Rius Sanjuan Knowledge Ecology International (KEI) ACTA: a threat to exceptions and.

Slides:



Advertisements
Similar presentations
Intellectual property rights and procurement = international developments & national experiences = Bi-regional Workshop on procurement and supply management.
Advertisements

Working world wide against HIV for the health and human rights of men who have sex with men Working world wide against HIV for the health and human rights.
WTO Dispute DS362 China vs. United States
World Intellectual Property Organization (WIPO) Dispute Settlement and Effective Enforcement of IP.
The Truth About ACTA Professor Michael Geist Canada Research Chair in Internet and E-commerce Law University of Ottawa, Faculty of Law.
Use of competition rules to address abuses of intellectual property rights CARRIBEAN REGIONAL WORKSHOP ON INTELLECTUAL PROPERTY AND ACCESS TO MEDICINES,
Interface between patent and sui generis systems of protection of plant varieties The 1978 UPOV Act does not allow both systems to be applied to the same.
International Experiences in Respect of Civil Remedies in IPR Litigation International Academic and Practical Conference on Current Issues Concerning Case.
China on the way to a high-technology country: The legal policy perspective Stefan Luginbuehl Lawyer, International Legal Affairs.
Challenges and Opportunities to Utilize TRIPS Flexibilities in Current Ukrainian Legislation: Potential Impact of IP Provisions in the Proposed EU FTA.
EU: Bilateral Agreements of Member States
EU: Bilateral Agreements of Member States. Formerly concluded international agreements of Member States with third countries Article 351 TFEU The rights.
The Korus FTA Will Lead to Higher Drug Prices in Korea
Intellectual Property Rights, Services and Trade Facilitation CARSTEN FINK African/LDCs Ambassadors Seminar on Post-Hong Kong Assessment of the Doha Round,
A New Pathway for Follow-on Biologics Presented by: Steve Nash May 7, 2010.
Exception to rules on free trade Need to strike a balance between free trade and other values. Member can justify measures incompatible with WTO Agreements.
ENVIRONMENTAL LIABILITY IN GREECE THE LEGAL FRAMEWORK & THE ROLE OF FINANCIAL GUARANTEES/ INSURANCE PRODUCTS TO COVER OPERATORS’ RESPONSIBILITIES UNDER.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
A very short introduction to patents & access to medicines.
Patent Related Flexibilities in the Pharmaceutical Field
Issues Pertinent for Action in the South Presentation to Partners in Population and Development: Meeting on Accelerating Essential Health Commodity Security.
IPR enforcement in the EU Evidence of impact of on the access to generics Johanna von Braun University of Cape Town, South Africa Kiev, 21/22 nd June 2010.
The emergence of an Enforcement Agenda Intellectual Property Rights and Access to Essential Medicines: Challenges and Opportunities in Free Trade Agreement.
PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
Overview +Recap +Legal framework - points of interest +Next steps +Questions.
CAPACITY BUILDING TRAINING PROGRAMME ON INTELLECTUAL PROPERTY RIGHTS AND RELATED WTO ISSUES April 28-May 2, 2008 Session 3 Enforcement under the TRIPS.
1 CUTS International Capacity Building Training Programme on Advance IPR, WTO-Related Issues and Patent Writing April 28-May 02, 2008, Jaipur Session 10.
1 SECTION 337 INVESTIGATIONS Managing Intellectual Property IP In China April 30, 2013 New York, New York.
Access to Genetic Resources & Traditional Knowledge The Bellagio compulsory cross-licensing proposal for benefit sharing consistent with more competition.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
IBT - Electronic Commerce Privacy Concerns Victor H. Bouganim WCL, American University.
UNCTAD/CD-TFT 1 Exclusive Rights and Public Access – Flexibilities in International Agreements and Development Objectives The Public Health Example 21.
O VERVIEW OF P UBLIC H EALTH -R ELATED TRIPS F LEXIBILITIES Sisule F. Musungu, IQsensato (
1 FRAND COMMITMENTS AND EU COMPETITION LAW Thomas Kramler European Commission, DG Competition (The views expressed are not necessarily those of the European.
Durban, South Africa January 29 to 31, 2013 Topic 17: Research and Regulatory Review Exception Regional Seminar for Certain African Countries on the Implementation.
© 2008 International Intellectual Property June 24, 2009 Class 8 Patents: Multilateral Agreements (WTO TRIPS); Global Problem of Patent Protection for.
© A. Kur IP in Transition – Proposals for Amendment of TRIPS Annette Kur, MPI Munich.
UNCTAD/CD-TFT 1 IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade.
UNCTAD/CD-TFT 1 Basic Features of the Multilateral Systems of Patents and Regulatory Test Data Development Dimensions of Intellectual Property Rights Hanoi.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
Regional Dialogue on EPAs, IP and Sustainable Development for ECOWAS Countries Dialogue organised by ICTSD, ENDA Tiers Monde & QUNO Saly (Dakar), Senegal,
A: Copy –Rights – Artistic, Literary work, Computer software Etc. B: Related Rights – Performers, Phonogram Producers, Broadcasters etc. C: Industrial.
Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies By Yvonne Nkrumah Legal Counsel, Ghana Food and Drugs Board.
‘Linkage’ & other TRIPS+ provisions: a public health perspective Karin Timmermans World Health Organization Seminar “Data exclusivity and patent Bangkok.
PATENTS, INTEGRATED CIRCUITS, AND INDUSTRIAL DESIGNS Presented By: Navdeep World Trade Organization.
Durban, South Africa January 29 to 31, 2013 Topic 13: The Effective Administrative Process for the Grant of Compulsory Licenses Regional Seminar for Certain.
The Third Revision of the Chinese Patent Law State Intellectual Property Office of P.R.C Dec
Intellectual Property and Public Policy: Application of Flexibilities in the International IP and Trade system --Limitation and Exceptions for Education.
Sangmin Song, Director, Anti-Monopoly Div., KFTC MRFTA & IP Rights 1.
FREE TRADE AGREEMENTS Prathibha Siva Lawyers Collective HIV/AIDS Unit, India East Africa Consultation, September 2010.
International Intellectual Property Prof. Manheim Spring, 2007 Patent Compulsory Licensing Copyright © 2007.
Dialogue on Competition Policy and Intellectual Property *
Overview of presentation
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
MGT601 SME MANAGEMENT.
ANTI-COUNTERFEITING TRADE AGREEMENT
Exception to rules on free trade
Intellectual Property Protection and Access to Medicines
Patent law update.
WIPO NATIONAL SEMINAR ON INTELLECTUAL PROPERTY RIGHTS AND THE PROTECTION OF PHARMACEUTICAL PRODUCTS Damascus, April 25 and 26, 2005 Current issues on Intellectual.
Data protection issues in regulatory investigations
SPCs and the unitary patent package
IP Protection under the WTO
Sub-Regional Meeting for ASEAN Countries on the Marrakesh Treaty and the Production and Exchange of Accessible Books by the World Intellectual Property.
IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade Agreements.
National remedies and national actions
INTELLECTUAL PROPERTY RIGHTS (IPR) IN FP7
The International Legal Framework
Intellectual Property Rights in Medicines Procurement
Presentation transcript:

American University Washington Colleague of Law October 2010 Judit Rius Sanjuan Knowledge Ecology International (KEI) ACTA: a threat to exceptions and limitations as limits to remedies

What’s ACTA? Why it matters? Protecting Pharmaceutical Monopolistic Power through secret negotiations Limitations & exceptions to IPR (flexibilities) can be done as limits on rights OR limits on remedies to infringement  Differences between Part II & Part III WTO TRIPS Agreement  Some L&E are easier to implement as limits on Remedies, than on Rights  ACTA deals with Remedies, without balance

WTO TRIPS Agreement Art 44 of TRIPS: Right to issue injunctions: The judicial authorities shall have the authority to order a party to desist from infringement… Limitations: a) Innocent third parties are protected: members are not obliged to to grant injunctions in respect of protected subject matter acquired or ordered by a person prior to knowing or having reasonable grounds to know that dealing in such subject matter would entail the infringement of an intellectual property right; and b) Members can limit rights holders to a remedy in damages: under Art 44.2, where an injunction would be inconsistent with a Member's law, declaratory judgments and adequate compensation must be available and enough. Art 45 of TRIPS

Limitations and Exceptions to Remedies Some examples I Judicially ordered compulsory licenses  U.S SC eBay v. MercExchange Jurisprudence  If a court finds injunctive relief inappropriate (4 factors/ “the public interest would not be disserved by a permanent injunction”), it can instead choose to issue a “reasonable royalty”.  2006: Cordis J&J on medical devices for performing angioplasty/ 2008: Abbott on Hepatitis C virus genotyping test kits/ 2009: Globus Medical on devices and methods used by spinal surgeons to stabilize bony structures/ India Jurisprudence

Limitations and Exceptions to Remedies Some examples II Statutory exceptions and limitations to remedies:  No injunctions available if compensation E.g. 28 USC 1498 automatic compulsory licenses for uses "by or for the government”.  No Injunctions neither compensation available E.g. US Health Care Reform bill – new regulatory pathways for generic/biosimilar biologic drugs. When patents are not disclosed timely to potential competitors, no injunction or damages available. Caps on Damages

Injunctions, Damages & Access to Medicines ACTA will affect both Access and Innovation to Medicines =  Limitations & Exceptions have a positive effect by accelerating the availability of generics to patients  They also have the potential to change business model in drug development. Exceptions sometimes transform patents in rights to remuneration, without allowing the exclusion of competition & the limitation of technology transfer WHA 61.21: Incentive mechanisms that de-link cost of R&D from price of products Liability Rules (only remedy for certain infringements would be an administrative just compensation) or no remedies at all available (nor injunctions or damages)

Injunctions (Leaked: January 18, 2010) Option 1: In civil judicial proceedings concerning the enforcement of [Can/NZ: copyright or related rights and trademarks] [US/J: intellectual property rights], each Party shall provide that its [US/J: judicial authorities] [NZ: competent authorities] shall have the authority to issue an order to a party to desist from an infringement, including an order to prevent infringing goods from entering into the channels of commerce [US/Aus/Kor/Mor/NZ: and to prevent their exportation]. Option 2: [EU: Each Party shall ensure that, where a judicial decision is taken finding an infringement of an intellectual property right, the judicial authorities may issue against the infringer an injunction aimed at prohibiting the continuation of the infringement. The Parties shall also ensure that right holders are in a position to apply for an injunction against intermediaries whose services are used by a third party to infringe an intellectual property right.] [NZ: Does not support the inclusion of this provision] [CAN: Need to address statutory limitations]

Injunctions (Leaked: July 1, 2010) [EU/Sing: 1.] In civil judicial proceedings concerning the enforcement of [Can/NZ/Aus/US/Sing/Mex: copyright or related rights and trademarks] [J/EU: intellectual property rights], each Party shall provide that its judicial authorities shall have the authority [Can/AUS: subject to any statutory limitations under its domestic law] [US/Kor/J/EU/CH/Mex: subject to any statutory limitations under its domestic law] to issue an order to a party to desist from an infringement, including an order to prevent infringing goods from entering into the channels of commerce. [EU/CH: 2.The Parties [NZ/Mor/Mex: may] shall also ensure that right holders are in a position to apply for an injunction against intermediaries whose services are used by a third party to infringe an intellectual property right].

Current: Injunctions (October 6, 2010) Each Party shall provide that, in civil judicial proceedings concerning the enforcement of intellectual property rights, its judicial authorities shall have the authority to issue an order against a party to desist from an infringement, and inter alia, an order to that party or, where appropriate, to a third party over whom the relevant judicial authority exercises jurisdiction, to prevent infringing goods from entering into the channels of commerce. Notwithstanding the other provisions of this Section, a Party may limit the remedies available against use by government, or by third parties authorized by a government, without the authorization of the right holders to the payment of remuneration provided that the Party complies with the provisions of Part II of the TRIPS Agreement specifically addressing such use. In other cases, the remedies under this Section shall apply or, where these remedies are inconsistent with a Party’s law, declaratory judgments and adequate compensation shall be available.

ACTA & Damages Cap on damages are good both for access and for innovation Current ACTA wording require courts to consider “any legitimate measure of value submitted by the right holder,” including “the value of the infringed good or service, measured by... the suggested retail price.” ACTA text seems to suggest the courts be required to consider use of the entire market value rule for patents (EMVR) The proposed high levels for damages will affect current law and jurisprudence and the possibility of future legislative reforms.

Damages (Leaked: January 18, 2010) 1. Each Party shall provide that: (a) in civil judicial proceedings, [US/J; its judicial authorities] [Mex/NZ: or competent authorities] [EU/NZ: on application of the{EU: injured party}{NZ:right holder}] shall have the authority to order the infringer [EU/NZ: who knowingly or with reasonable grounds to know engaged in infringing activity] of [Can/Sing/NZ: copyright or related rights and trademarks] [US/J: intellectual property rights] to pay the right holder (i) damages adequate to compensate for the [EU: actual] injury the right holder has suffered as a result of the infringement 3 ; or [EU: or] (ii) [US/Mor/Aus/Kor/Sing: at least in the case of copyright or related rights infringement and trademark counterfeiting,][MX: in the case of IPR infringements] the profits of the infringer that are attributable to the infringement, which may be presumed to be the amount of damages referred to in clause (i)[Aus/Sing/NZ/EU: which may be presumed to be the amount of damages referred to in clause (i)]; and [EU: Delete (ii){as originally proposed?} and move (ii) into paragraph 2.2.1(b)--please clarify]

Damages (Leaked: January 18, 2010) 1. Each Party shall provide that: [(iii) Can/NZ: For greater certainty, a Party may limit or exclude damages in certain special cases.] (b) in determining the amount of damages for [Can/Sing/NZ: copyright or related rights infringement][MX: IPR] infringement [US/J: of intellectual property rights] [Can/Sing: and trademark counterfeiting], its [US/J:judicial][NZ: competent] authorities [US/J: shall][Aus/Can/NZ: may] consider, inter alia, [Can/NZ: any legitimate measure of value that may be submitted by the right holder, including] [EU/Can/NZ: the lost profits], the value of the infringed good or service, measured by the market price, [Can: or] the suggested retail price [NZ: suggested retail price], or other legitimate measure of value submitted by the right holder [Can/NZ: or other legitimate measure of value submitted by the right holder], [EU: the profits of the infringer that are attributable to the infringement]

Current: Damages (October 6, 2010) 1. Each Party shall provide that in civil judicial proceedings, its judicial authorities shall have the authority to order the infringer who knowingly or with reasonable grounds to know, engaged in infringing activity of intellectual property rights, to pay the right holder damages adequate to compensate for the injury the right holder has suffered as a result of the infringement. In determining the amount of damages for infringement of intellectual property rights, its judicial authorities shall have the authority to consider, inter alia, any legitimate measure of value submitted by the right holder, which may include the lost profits, the value of the infringed good or service, measured by the market price, the suggested retail price.

ACTA Now October 2010 version is a significant improvement over previous versions of the texts. Example:  Important safeguards have been added (privacy, public health, objectives and purposes)  The border measures have been significantly improved  Footnote 2 / possibility of patents excluded  Improvements on the injunctions section Success based on leaked text and global activism However, there are outstanding issues that are important. E.g. Data Exclusivity/ Limits on injunctions without compensation/ Damages…

Future, ACTA PLUS for all Bitter victory - ACTA is a blank check – Creation of a new institution/process with the mandate to amend ACTA & extend to developing countries Not clear rules of civil society, developing countries and other experts participation and legislative power scrutiny  Direct attack on WTO/WIPO as norm setting forums with developing countries & civil society participation Double standard: Article 1.2 ACTA?

More Information Knowledge Ecology International Subscribe to: IP-health Mailing list Judit Rius Sanjuan